Aurobindo Pharma has surged nearly 9% at Rs 259, also its 52-week high on BSE, after reporting a healthy 80% year-on-year (yoy) growth in consolidated adjusted net profit at Rs 245 crore for the quarter ended September 30, 2013 (Q2) on back of strong operational performance. The pharmaceutical company had profit of Rs 136 crore in a year ago quarter.
Net sales grew strongly by 28.1% yoy to Rs 1,897 crore led by a robust growth in formulations. The growth in formulation was driven by the USA markets, which posted a yoy growth of 72.0%.
The EBITDA margin during the quarter has improved by 620bps yoy at 22.9% due to improved business mix resulting in decrease in materials consumption, staff cost and other expenses to net operating income, Aurobindo Pharma said in a statement.
The counter has seen huge trading activities with a combined 8.02 million shares already changed hands till 1010 hours against an average sub 2 million shares that were traded daily in past two weeks on BSE and NSE.
Net sales grew strongly by 28.1% yoy to Rs 1,897 crore led by a robust growth in formulations. The growth in formulation was driven by the USA markets, which posted a yoy growth of 72.0%.
The EBITDA margin during the quarter has improved by 620bps yoy at 22.9% due to improved business mix resulting in decrease in materials consumption, staff cost and other expenses to net operating income, Aurobindo Pharma said in a statement.
The counter has seen huge trading activities with a combined 8.02 million shares already changed hands till 1010 hours against an average sub 2 million shares that were traded daily in past two weeks on BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%